V
VIVA Biotech Holdings
HKEX:1873
VIVA Biotech Holdings
HKEX:1873
Price:
0.79 HKD
25.4%
Market Closed
Updated:
May 17, 2024
VIVA Biotech Holdings
Interest Income Expense
|
VIVA Biotech Holdings
Interest Income Expense Peer Comparison
Comparables:
603259
300759
2269
300347
1548
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
V
|
VIVA Biotech Holdings
HKEX:1873
|
Interest Income Expense
-¥433.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Interest Income Expense
¥668.3m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Interest Income Expense
¥34.9m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Interest Income Expense
¥80.2m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Interest Income Expense
¥612.2m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
35%
|
CAGR 10-Years
48%
|
|
|
Genscript Biotech Corp
HKEX:1548
|
Interest Income Expense
$51.5m
|
CAGR 3-Years
83%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
See Also
What is VIVA Biotech Holdings's Interest Income Expense?
Interest Income Expense
-433.5m
CNY
-433.5m
CNY
Based on the financial report for Dec 31, 2023, VIVA Biotech Holdings's Interest Income Expense amounts to -433.5m CNY.
What is VIVA Biotech Holdings's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
39%
39%
Over the last year, the Interest Income Expense growth was 39%.
You don't have any saved screeners yet
